相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
Min Li et al.
AAPS JOURNAL (2017)
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Romuald Bellmann et al.
INFECTION (2017)
New pharmacological opportunities for the treatment of invasive mould diseases
Marie-Pierre Ledoux et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Fungal fatal attraction: a mechanistic review on targeting liposomal amphotericin B (AmBisome®) to the fungal membrane
Linda Soo Hoo
JOURNAL OF LIPOSOME RESEARCH (2017)
Refinement of Mouse Protocols for the Study of Platelet Thromboembolic Responses In Vivo
Francesca Rauzi et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Initiation of phospholipomannan β-1,2 mannosylation involves Bmts with redundant activity, influences its cell wall location and regulates β-glucans homeostasis but is dispensable for Candida albicans systemic infection
F. Courjol et al.
BIOCHIMIE (2016)
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
Aline Raquel Voltan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Development of an itraconazole encapsulated polymeric nanoparticle platform for effective antifungal therapy
Xiang Ling et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Saturated Metabolism of Voriconazole N-Oxidation Resulting in Non linearity of Pharmacokinetics of Voriconazole at Clinical Doses
Takahiro Yamada et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
New Developments in Liposomal Drug Delivery
Bhushan S. Pattni et al.
CHEMICAL REVIEWS (2015)
Liposomal voriconazole (VOR) formulation for improved ocular delivery
Fernando Augusto Pires de Sa et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications
Juliette Merian et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection
Pranab Jyoti Das et al.
MOLECULAR PHARMACEUTICS (2015)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe et al.
FRONTIERS IN PHARMACOLOGY (2015)
Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells
Jose Pedro Lopes et al.
SCIENTIFIC REPORTS (2015)
Antifungal Pharmacokinetics and Pharmacodynamics
Alexander J. Lepak et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy
Tyree H. Kiser et al.
CRITICAL CARE (2015)
Tissue Penetration of Antifungal Agents
Timothy Felton et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Update on the antibiotic resistance crisis
Gian Maria Rossolini et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Overview of vertebrate animal models of fungal infection
Tobias M. Hohl
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Terry Roemer et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Passive targeting of nanoparticles to cancer: A comprehensive review of the literature
Remon Bazak et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Nanoantibiotics: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era
Ae Jung Huh et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis
Michail S. Lionakis et al.
JOURNAL OF INNATE IMMUNITY (2011)
Antifungal Susceptibility and Virulence Attributes of Bloodstream Isolates of Candida from Hong Kong and Finland
C. J. Seneviratne et al.
MYCOPATHOLOGIA (2011)
Multiplex Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification in Human Plasma of Fluconazole, Itraconazole, Hydroxyitraconazole, Posaconazole, Voriconazole, Voriconazole-N-Oxide, Anidulafungin, and Caspofungin
Laurent Arthur Decosterd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Development of Nanoparticles for Antimicrobial Drug Delivery
L. Zhang et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane
Kosuke Shimizu et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cyclodextrin (SBECD)
David R. Luke et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Targeted nanodelivery of drugs and diagnostics
Margaret A. Phillips et al.
NANO TODAY (2010)
Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring
Celine Eiden et al.
XENOBIOTICA (2010)
Antifungal serum concentration monitoring: an update
Megan L. Goodwin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?
Ursula Theuretzbacher
CURRENT OPINION IN PHARMACOLOGY (2007)
Pharmacokinetics and pharmacodynamics of antifungals
David Andes
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2006)
Pharmacokinetic/pharmacodynamic profile of voriconazole
Ursula Theuretzbacher et al.
CLINICAL PHARMACOKINETICS (2006)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human
SJ Roffey et al.
DRUG METABOLISM AND DISPOSITION (2003)
Improving the mouse model for studying the efficacy of voriconazole
JR Graybill et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis
D Andes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Rational dosing of antibiotics:: the use of plasma concentrations versus tissue concentrations
P Liu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes
RB Campbell et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Virulence factors of Candida albicans
RA Calderone et al.
TRENDS IN MICROBIOLOGY (2001)
A good practice guide to the administration of substances and removal of blood, including routes and volumes
KH Diehl et al.
JOURNAL OF APPLIED TOXICOLOGY (2001)
Evaluation of voriconazole pharmacodynamics using time-kill methodology
ME Klepser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system
AH Groll et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications
H Pinto-Alphandary et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
